Kirk O - Search Results

1

All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study.

Kraef C, Tusch E, Singh S, Østergaard L, Fätkenheuer G, Castagna A, Moreno S, Kusejko K, Szetela B, Kuznetsova A, Tomažič J, Ranin J, Zangerle R, Mansson F, Marchetti G, De Wit S, Clarke A, Gerstoft J, Podlekareva D, Peters L, Reekie J, Kirk O; EuroSIDA Study Group. Kraef C, et al. Among authors: kirk o. Lancet Reg Health Eur. 2024 Jun 25;44:100989. doi: 10.1016/j.lanepe.2024.100989. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39036304 Free PMC article.

2

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.

Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, D'Arminio Monforte A, Hermans P, Goebel FD, Blaxhult A, Kirk O, Phillips AN; EuroSIDA Study Group. Lundgren JD, et al. Among authors: kirk o. J Infect Dis. 2002 Jan 15;185(2):178-87. doi: 10.1086/338267. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807691 Free article.

3

Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.

Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW, Ledergerber B, Lundgren JD, Furrer H; European HIV Cohorts. Kirk O, et al. Ann Intern Med. 2002 Aug 20;137(4):239-50. doi: 10.7326/0003-4819-137-4-200208200-00008. Ann Intern Med. 2002. PMID: 12186514

4

K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

Røge BT, Katzenstein TL, Obel N, Nielsen H, Kirk O, Pedersen C, Mathiesen L, Lundgren J, Gerstoft J. Røge BT, et al. Among authors: kirk o. Antivir Ther. 2003 Apr;8(2):173-82. Antivir Ther. 2003. PMID: 12741630 Clinical Trial.

5

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H, Katzenstein TL, Lundgren JD. Gerstoft J, et al. Among authors: kirk o. AIDS. 2003 Sep 26;17(14):2045-52. doi: 10.1097/00002030-200309260-00005. AIDS. 2003. PMID: 14502007 Clinical Trial.

6

A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.

Kirk O, Lundgren JD, Pedersen C, Mathiesen LR, Nielsen H, Katzenstein TL, Obel N, Gerstoft J. Kirk O, et al. Antivir Ther. 2003 Dec;8(6):595-602. Antivir Ther. 2003. PMID: 14760893 Clinical Trial.

7

Changing incidence of central nervous system diseases in the EuroSIDA cohort.

d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J; EuroSIDA Study Group. d'Arminio Monforte A, et al. Among authors: kirk o. Ann Neurol. 2004 Mar;55(3):320-8. doi: 10.1002/ana.10827. Ann Neurol. 2004. PMID: 14991809

8

Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.

Phillips AN, Ledergerber B, Horban A, Reiss P, Chiesi A, Kirk O, Mulchany F, Fisher M, Machala L, Lundgren JD; EuroSIDA Study Group. Phillips AN, et al. Among authors: kirk o. AIDS. 2004 Sep 3;18(13):1795-804. doi: 10.1097/00002030-200409030-00008. AIDS. 2004. PMID: 15316340

9

Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; EuroSIDA study group. Mocroft A, et al. Among authors: kirk o. AIDS. 2004 Nov 19;18(17):2333-7. doi: 10.1097/00002030-200411190-00018. AIDS. 2004. PMID: 15577550

10

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group. Konopnicki D, et al. Among authors: kirk o. AIDS. 2005 Mar 24;19(6):593-601. doi: 10.1097/01.aids.0000163936.99401.fe. AIDS. 2005. PMID: 15802978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters